<DOC>
	<DOCNO>NCT01028911</DOCNO>
	<brief_summary>This study evaluate safety , tolerability blood level PF-03654746 subject mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>A Study Evaluate Safety , Tolerability , Blood Levels PF-03654746 Subjects With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Probable Alzheimer 's disease Mini Mental State Examination score 1826 inclusive Aged 5585 Dementia Alzheimer 's disease Clinically significant cardiovascular disease past 6 month prior screen Creatinine clearance &lt; 30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Phase 1 Alzheimer 's disease Safety Tolerability Pharmacokinetics</keyword>
</DOC>